• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.26% Nasdaq Down 0.34%

    More On CLVLY

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Clinuvel Pharmaceuticals Limited (CLVLY)

    -Other OTC
    2.21 Down 0.04(1.78%) Jul 6, 9:30AM EDT
    |Pre-Market : NaN
    Add to Portfolio
    Prev Close:2.25
    Open:2.21
    Bid:N/A
    Ask:N/A
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:2.13 - 2.21
    52wk Range:1.38 - 5.00
    Volume:2,430
    Avg Vol (3m):6,771
    Market Cap:93.68M
    P/E (ttm):N/A
    EPS (ttm):-0.18
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    • No Headlines available for CLVLY at this time.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):43.17
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing drugs for the treatment of a range of skin disorders in Australia. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback